Nextcure (NXTC)10% owner bought ~$386K
ADAR1 Capital Management, 10% owner at Nextcure, bought ~$386K of Nextcure shares.
- ~$386K
- Approx. value · 78K sh @ $4.96
- 686K
- Holds after · shares reported
- Traded
- Jul 30, 2026
- Filed
- Aug 3, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 18, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On June 18, 2026, the stockholders of NextCure, Inc. (the “Company”) approved the amendment and restatement of the NextCure, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan” and, as amended and restated, the “A&R 2019 Plan”) at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
- Jul 14, 2026Company filing · Form 8-K · Material agreement, RestructuringAnnounced job cuts, closures or a restructuring, and control of the company changed hands (and 4 more items)“On July 14, 2026, NextCure and Avere issued a joint press release announcing the entry into the Merger Agreement. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference, except that the information contained on the websites referenced in the press release is not incorporated herein by reference.”
- Jul 27, 2026Insider · 10 days before results10% owner purchased ~$39K of NXTC shares in the open market
- Jul 28, 2026Insider · 9 days before results10% owner purchased ~$32K of NXTC shares in the open market
- Jul 29, 2026Insider · 1 personInsiders: 2 purchases (~$17K)
- Jul 30, 2026 · this disclosureInsider · 7 days before results10% owner purchased ~$386K of NXTC shares in the open market
What came next
- Jul 30, 2026Insider · 1 personInsiders: 5 purchases (~$1.1M)
- Jul 31, 2026Insider · 1 personInsiders: 3 purchases (~$179K)
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 10, 2026InsiderInsider sold ~$185K of NXTC shares in the open market
- Sep 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Nextcure
For Nextcure, OQRO holds 14 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NXTC page.
Other recent filings by ADAR1 Capital Management, LLC, 10% owner
- SEC Form 4 at Inmed Pharmaceuticals (INM)Oct 8, 2026
- SEC Form 4 at Inmed Pharmaceuticals (INM)Oct 8, 2026
- SEC Form 4 at Inmed Pharmaceuticals (INM)Oct 8, 2026
- SEC Form 4 at Inmed Pharmaceuticals (INM)Oct 6, 2026
- SEC Form 4 at Inmed Pharmaceuticals (INM)Oct 6, 2026
The full history of ADAR1 Capital Management, LLC, 10% owner is on the profile page.
How this filing works
Other disclosures at Nextcure
- SEC Form 4Aug 12, 2026
- SEC Form 4Aug 3, 2026
- SEC Form 4Aug 3, 2026
- SEC Form 4Aug 3, 2026
- SEC Form 4Aug 3, 2026
- SEC Form 4Aug 3, 2026
Everything OQRO holds on this company is on its NXTC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data